The peptide is operating in a different tier entirely
CrossRef Computational approaches to predicting treatment response to obesity using neuroimaging Leonard Kozarzewski, Lukas Maurer, Anja Mhler, Joachim Spranger, Martin Weygandt Reviews in Endocrine and Metabolic Disorders.2022
Instead, it is designed as a consistent daily tool to help regulate hunger, improve digestion, and support gradual weight management over time
Other associated problems include arthritis outside the spine, inflammation at the points where tendons or ligaments attach to bones, and swollen fingers or toes (also known as sausage digits)
Considerations & Potential Risks While the benefits are promising, GLP-1RA users have also reported some increased risks, including: Gastrointestinal issues (nausea, heartburn, abdominal pain, and gastroparesis)
Since semaglutide is typically injected once weekly and B12 is given monthly or taken daily, they operate on different timelines